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AbstrACt
Introduction Interpregnancy interval (IPI) is the length 
of time between a birth and conception of the next 
pregnancy. Evidence suggests that both short and long IPIs 
are at increased risk of adverse pregnancy and perinatal 
outcomes. Relatively less attention has been directed 
towards investigating the effect of IPI on pregnancy 
complications, and the studies that have been conducted 
have shown mixed results. This systematic review will 
aim to provide an update to the most recent available 
evidence on the effect of IPI on pregnancy complications.
Method and analysis We will search electronic 
databases such as Ovid/MEDLINE, EMBASE, CINAHL, 
Scopus, Web of Science and PubMed to identify peer-
reviewed articles on the effects of IPI on pregnancy 
complications. We will include articles published from start 
of indexing until 12 February 2018 without any restriction 
to geographic setting. We will limit the search to literature 
published in English language and human subjects. Two 
independent reviewers will screen titles and abstracts and 
select full-text articles that meet the eligibility criteria. The 
Newcastle-Ottawa tool will be used to assess quality of 
observational studies. Where data permit, meta-analyses 
will be performed for individual pregnancy complications. 
A subgroup analyses by country categories (high-income 
vs low and middle-income countries) based on World Bank 
income group will be performed. Where meta-analysis is 
not possible, we will provide a description of data without 
further attempt to quantitatively pool results.
Ethics and dissemination Formal ethical approval is not 
required as primary data will not be collected. The results 
will be published in peer-reviewed journals and presented 
at national and international conferences.
PrOsPErO registration number CRD42018088578.
IntrOduCtIOn 
The length of time between birth and the 
beginning of the following pregnancy (inter-
pregnancy interval (IPI)) has been linked 
to an increased risk of adverse outcomes in 
infants and their mothers.1–4 To reduce this 
risk, the WHO and the American College 
of Obstetrics and Gynaecology suggest an 
interval of at least 2 years and a minimum 
of 18 months following a live birth, respec-
tively.2 3 IPI is viewed as a potential modifiable 
risk factor for adverse maternal and perinatal 
outcomes for planned pregnancies.
The importance of birth spacing has been 
a focus for perinatal researchers and poli-
cy-makers for nearly a century.5 Studies have 
revealed that both short and long IPIs are 
potentially associated with increased risk 
of adverse perinatal outcomes, including 
stillbirth, small for gestational age, preterm 
delivery and neonatal death.1 3 4 6 Conversely, 
the effect of IPI on complications during 
pregnancy has received less attention.
There is a growing body of literature that 
recognises the association between short IPIs 
and risk of premature rupture of membrane 
(PROM),7 8 placental abruption, placenta 
praevia,9 uterine rupture for women who 
previously delivered by caesarean section10 11 
and gestational diabetes.12 Similarly, long IPIs 
have long been associated with increased risk 
of pre-eclampsia13 14 and labour dystocia.4
Although previous reviews1 15 have 
suggested that IPI is associated with risk of 
pregnancy complications, these reviews did 
not identify a sufficient number of studies 
to evaluate the effect of IPI on pregnancy 
complications.
The two systematic reviews investigating the 
effect of IPI on maternal health/outcomes 
were published 10 years and 5 years ago, 
strengths and limitations of this study
 ► The proposed systematic review and meta-analy-
sis will adhere to the Preferred Reporting Items for 
Systematic Reviews and Meta Analyses guidelines.
 ► The review aims to provide an update to the most 
recent available evidence on the effect of interpreg-
nancy interval on pregnancy complications.
 ► Two independent reviewers will screen titles and 
abstracts, study eligibility and perform the quality 
assessment.
 ► This review will only include the published literature 
in the English language.
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respectively,1 15 and there has since been increasing atten-
tion paid to this area and a number of publications.12 16–19 
Meanwhile, the reviews have been either limited to few 
maternal outcomes of interest (ie, maternal haemorrhage, 
PROM)9 or not included results from studies published in 
the last decade.1 A further systematic review of the effect 
of IPI on pregnancy complications is warranted, with a 
view to meta-analysis of the outcomes.
This systematic review will explore the effect of IPI 
on pregnancy complications. The information obtained 
from this review is important to inform women, their 
family and clinicians regarding IPI. The main purpose of 
the systematic review is to update, compile and critically 
review the evidence on the effects of IPI on pregnancy 
complications.
MEthOds And dEsIgn
Population
The systematic review will include multiparous women 
with information on length of interval between two 
consecutive pregnancies. We will not exclude studies that 
implemented restrictions on age, ethnic group, parity 
and socioeconomic status.
study design
This systematic review will include all observational 
prospective or retrospective studies that have assessed 
the effects of IPI with various pregnancy complications 
according to birth interval categories. Randomised 
controlled trials (RCT) are unlikely to be identified due 
to exposure of interest but will be included if available.
Comparator(s)/control
When assessed as a categorical variable, the reference IPI 
category will be 18–23 months.
Outcomes
The outcomes of interest in this review are pregnancy 
complications, defined as gestational diabetes, gestational 
hypertension, pre-eclampsia, uterine rupture, placental 
abruption, placenta praevia, PROM and labour dystocia.
dAtA sOurCEs And sEArCh strAtEgy
We will conduct electronic searches in Ovid/MEDLINE, 
EMBASE, CINAHL, Scopus, Web of Science and PubMed 
databases, using a combination of medical subject head-
ings (MeSH) and keywords related to IPI and pregnancy 
complications. We will include articles published from 
start of indexing until 12 February 2018 without any 
restriction on study type or geographic setting. A search 
strategy was developed (see table 1 for search criteria and 
online Supplementary file 1 for detailed search strategy 
for each database).
The search strategy will be piloted across each database 
to improve the effectiveness of the final search. We will 
also check the reference list of primary studies that will be 
selected for full-text evaluation for additional potentially 
relevant studies not identified by the electronic search. 
We will include studies published in peer-reviewed jour-
nals conducted with human populations and restricted 
to English language. Corresponding authors will be 
contacted to request information not presented in the 
manuscripts that are required for the review.
ElIgIbIlIty CrItErIA
Inclusion criteria
The studies to be included in this review are required to 
fulfil two criteria.
Study design criterion: all observational studies evaluating 
the association between IPI and pregnancy complications.
Exposure criterion: studies that investigate IPI or birth 
interval as the primary exposure. IPI is defined as 
the length of time between the end of a pregnancy and 
the start of the next pregnancy. Birth interval is defined as 
the time elapsed between the end of one pregnancy and 
the end of the next pregnancy.
Exclusion criteria
Studies will be excluded based on three criteria. (1) 
Non-primary studies: case series or reports, editorials, 
letters to the editor or reviews without original data. (2) 
Studies with insufficient information on adjusted effect 
(eg, unclear adjustment variable, missing CI estimates). 
(3) Studies that do not investigate IPI as a primary 
exposure.
study selection process and software
All unique studies identified from each electronic data-
base will be imported into an EndNote library. For repro-
ducibility and to expedite a future update of the review, 
this library will be published as online Supplementary 
data. Further screening of titles and abstracts will be 
accomplished by two independent investigators. Results 
will be stored using Covidence, a web-based software tool 
that (1) allows collation of search results, (2) screen 
abstracts and full text articles, (3) extract data from 
selected articles, (4) conduct risk of bias assessment and 
(5) resolve disagreements and export data. In accordance 
with Preferred Reporting Items for Systematic Reviews 
Table 1 Search criteria
Search terms
Interpregnancy 
interval 
Subject heading (MeSH) term: Birth interval
Keywords: ‘*birth interval’ or ‘*birth 
spacing’ or ‘*conception interval’ or 
‘*conception spacing’ or ‘*delivery interval’ 
or ‘*delivery spacing’ or ‘*pregnancy 
interval’ or ‘*pregnancy spacing’
Pregnancy 
complications
Subject heading (MeSH) term: ‘Pregnancy 
Complications’
Keywords: ‘obstetric complication*’ or 
‘maternal complication*’ or ‘maternal 
morbidit*’ or ‘maternal outcome*’
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and Meta-Analyses (PRISMA), a flow diagram will be used 
to report the screening process. From the set of studies 
screened by title and abstract, two reviewers will inde-
pendently screen full-text articles based on the eligibility 
criteria. Any discrepancies between the two reviewers 
for studies that have been included or excluded will be 
discussed first, if an agreement cannot be reached, a third 
investigator will be consulted for moderation. The reason 
for excluding each study will also be recorded.
Risk of bias (quality) assessment
The quality of included studies will be assessed by two 
independent reviewers using The Newcastle-Ottawa 
Scale for assessing quality of cohort and cross-sectional 
studies.20 Any disagreement which arises between the 
reviewers will be resolved through discussion with a third 
reviewer.
Data extraction
Data will be extracted from all included studies by two 
independent reviewers using a specifically developed 
data extraction form in line with the eligibility criteria 
and outcomes of interest. For each study, the following 
data will be extracted (1) author names, (2) publication 
year, (3) study period, (4) geographic location, (5) World 
Bank income category (at the time of publication), (6) 
study design, (7) sample size, (8) exposure, (9) outcome 
measure of interest, (10) adjustment or matching vari-
ables, (11) effect size and (12) response rate (where 
indicated).
Data synthesis and analysis
The final review will include data presented in summary 
tables and a narrative synthesis to describe the variables 
listed in the data extraction section. Where data permit, 
meta-analyses will be performed for individual pregnancy 
complications. We will apply random effects meta-anal-
ysis using the generic inverse variance method to explore 
the association between IPIs and pregnancy complica-
tions.21 22 We will calculate pooled odss ratio (OR) from 
all studies that provided adjusted OR or risk ratio with 
95% CIs for each pregnancy complication (outcome 
of interest). Egger’s weighted regression test will be 
used to assess publication bias.23 The I2 statistic will be 
reported as a measure of heterogeneity between studies.24 
Where meta-analysis is not possible, we will present data 
without quantitatively synthesising it. If the same data are 
presented in multiple studies, then those providing the 
most information will be considered.
Subgroup analyses
Subgroup analyses by country categories based on World 
Bank income group (high-income countries vs low and 
middle-income countries) will be performed.
Confidence in cumulative evidence
The quality of the findings on each outcome of interest 
across studies will be assessed using Grading of Recom-
mendations, Assessment, Development and Evaluations 
(GRADE) guidelines, which are developed by the GRADE 
Working Group.25 The GRADE approach will allow us to 
determine the quality of the evidence of each outcome. 
The GRADE system classifies the quality of evidence as 
very low (very uncertain effect estimates), low (further research 
will likely change the effect estimate), moderate (further 
research may change the estimate and our confidence in it) or 
high (further research is very unlikely to change our confi-
dence in the estimate of effect).
Patient and public involvement
Members of the community Healthy Pregnancies Consumer 
Reference Group will provide community and consumer 
perspectives to this study. This group will provide an 
insight into issues that affect their pregnancy planning 
decisions, contextualise results and provide participant 
experience.
Ethics and dissemination
Formal ethical approval is not required as primary 
data will not be collected. This protocol adheres to the 
PRISMA protocols guidelines.26 In addition, the findings 
of the systematic review will be reported according to the 
PRISMA statement.27
review registration
This review has been registered with International 
Prospective Register for Systematic Reviews (PROSPERO) 
under the identification code: CRD42018088578.
updates to study protocol
If any updates to the study protocol are required, these 
will be listed and included as supplementary information 
along with a final manuscript and updated on the PROS-
PERO register.
dIsCussIOn
Families want to know the best time at which they 
conceive their next child in order to have a safer preg-
nancy and healthy baby. Clinicians need evidence-based 
recommendations to provide advice on the optimal IPI 
leading to fewer maternal and perinatal complications. 
For planned pregnancies, IPI is modifiable, and such 
recommendations may therefore be useful for preventing 
adverse maternal/pregnancy outcomes. The current 
WHO recommendations, which suggest that women wait 
at least 2 years after delivering a live birth,2 were based on 
a review of observational studies predominantly in low-in-
come and middle-income populations, which may not be 
generalisable to high-income countries. Context specific 
and updated evidence is warranted to clarify whether the 
evidence of studies investigated the effect of IPI on preg-
nancy complications is sufficient for decision-making.
This will be a comprehensive systematic review inves-
tigating the effect of IPI on pregnancy complications. 
Previous reviews have been limited to few maternal 
outcome of interest15 or have not included results from 
studies published in the last 10 years.1 A systematic review 
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investigating effect of IPI on pregnancy complications is 
now warranted. Systematic documentation and synthe-
sising of literature on the effect of IPI on various preg-
nancy complications will be important to set and revise 
evidence-based guidelines for IPIs. By updating the 
current state of knowledge in IPI research, this review 
will provide a basis for guiding future studies and future 
global policies for family planning.
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